The Human Fertilisation and Embryology Authority has advised that its Scientific and Clinical Advances Advisory Committee has not made any specific new recommendations.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2022-10-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-10-28T13:59:01.83Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Human Embryo Experiments"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government, further to the Written Answer by Baroness Bloomfield of Hinton Waldrist on 3 October (HL2056), which new studies relating to the impact on children born from assisted reproductive technology treatments had led the expert Scientific and Clinical Advances Advisory Committee of the Human Fertilisation and Embryology Authority (HFEA) to consider new recommendations regarding (i) additional techniques with the aim of replacing mitochondria in embryos, (ii) genome editing of embryos that is not currently considered to be clinic-ready, and (iii) extending the 14-day limit for embryo research.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL2572"} , {"_about" : "http://data.parliament.uk/resources/1522034", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1522034/answer", "answerText" : {"_value" : "
No recent assessment has been made and we have no plans to implement such a suspension. We have frozen prescription charges for 2022/23 to assist with the cost of living. In addition to the single prescription charge, this also applies to Prescription Payment Certificates (PPCs). The cost of a 12 month PPC remains at £108.10, which can be paid in instalments, to allow people receive their required medicines for just over £2 a week. People on a low income who do not qualify for an exemption may be eligible for help with prescription charges through the NHS Low Income Scheme. Approximately 89% of National Health Service prescription items are dispensed free of charge.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2022-10-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-10-27T11:09:03.57Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Prescriptions: Concessions"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what assessment they have made of a temporary suspension of NHS prescription charges on (1) patients, (2) the NHS, and (3) the economy, given the rising cost of living; and what plans they have, if any, to implement such a suspension.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4167", "label" : {"_value" : "Biography information for Baroness Benjamin"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Benjamin"} ], "uin" : "HL2574"} , {"_about" : "http://data.parliament.uk/resources/1522035", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1522035/answer", "answerText" : {"_value" : "
No specific assessment has been made and there are no current plans to review or extend the prescription charge medical exemptions list to include long term conditions, such as sickle cell disease.<\/p>
Approximately 89% of prescription items are currently dispensed free of charge and there are a range of exemptions from prescription charges for which those with sickle cell disease may meet the eligibility criteria and be in receipt of free prescriptions. To support those who do not qualify for an exemption from prescription charges, the cost of prescriptions can be capped by purchasing a prescription pre-payment certificate, which can be paid for in instalments. A holder of a 12-month certificate can get all the prescriptions they need for just over £2 per week. Additionally, those on a low income who do not qualify for an exemption from prescription charges can also seek help under the NHS Low Income Service, which provides help with health costs on an income-related basis.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2022-10-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL2576"} , {"_value" : "HL2577"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-10-26T14:11:04.297Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sickle Cell Diseases: Prescriptions"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government, further to the All Party Parliamentary Group for Sickle Cell and Thalassaemia report No One's Listening: An Inquiry into the Avoidable Deaths and Failures of Care for Sickle Cell Patients in Secondary Care, published on 15 November 2021, what assessment they have made of the impact of prescription charges for people with sickle cell disease.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4167", "label" : {"_value" : "Biography information for Baroness Benjamin"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Benjamin"} ], "uin" : "HL2575"} , {"_about" : "http://data.parliament.uk/resources/1522036", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1522036/answer", "answerText" : {"_value" : "
No specific assessment has been made and there are no current plans to review or extend the prescription charge medical exemptions list to include long term conditions, such as sickle cell disease.<\/p>
Approximately 89% of prescription items are currently dispensed free of charge and there are a range of exemptions from prescription charges for which those with sickle cell disease may meet the eligibility criteria and be in receipt of free prescriptions. To support those who do not qualify for an exemption from prescription charges, the cost of prescriptions can be capped by purchasing a prescription pre-payment certificate, which can be paid for in instalments. A holder of a 12-month certificate can get all the prescriptions they need for just over £2 per week. Additionally, those on a low income who do not qualify for an exemption from prescription charges can also seek help under the NHS Low Income Service, which provides help with health costs on an income-related basis.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2022-10-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL2575"} , {"_value" : "HL2577"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-10-26T14:11:04.343Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sickle Cell Diseases: Prescriptions"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what steps they are taking to ensure the affordability of medication for people living with sickle cell disease.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4167", "label" : {"_value" : "Biography information for Baroness Benjamin"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Benjamin"} ], "uin" : "HL2576"} , {"_about" : "http://data.parliament.uk/resources/1522037", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1522037/answer", "answerText" : {"_value" : "
No specific assessment has been made and there are no current plans to review or extend the prescription charge medical exemptions list to include long term conditions, such as sickle cell disease.<\/p>
Approximately 89% of prescription items are currently dispensed free of charge and there are a range of exemptions from prescription charges for which those with sickle cell disease may meet the eligibility criteria and be in receipt of free prescriptions. To support those who do not qualify for an exemption from prescription charges, the cost of prescriptions can be capped by purchasing a prescription pre-payment certificate, which can be paid for in instalments. A holder of a 12-month certificate can get all the prescriptions they need for just over £2 per week. Additionally, those on a low income who do not qualify for an exemption from prescription charges can also seek help under the NHS Low Income Service, which provides help with health costs on an income-related basis.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2022-10-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL2575"} , {"_value" : "HL2576"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-10-26T14:11:04.407Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sickle Cell Diseases: Prescriptions"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what plans they have to introduce free NHS prescriptions for medical conditions with existing health inequalities, such as sickle cell disease.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4167", "label" : {"_value" : "Biography information for Baroness Benjamin"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Benjamin"} ], "uin" : "HL2577"} , {"_about" : "http://data.parliament.uk/resources/1522038", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1522038/answer", "answerText" : {"_value" : "
Ciprofloxacin has been continuously monitored on the Water Framework Directive Watch List for 4 years. Its removal is being considered as the Directive specifically states that no Watch List substances should be continuously monitored for more than 4 years.<\/p>
Ciprofloxacin is currently routinely monitored in England. Ciprofloxacin has been nominated and will be reviewed under the Environment Agency's chemical prioritisation and early warning system. This system allows the Environment Agency to consider the potential risks of emerging chemicals, including to surface waters (both freshwater and saline waters), groundwater, and soils. The system allows the Environment Agency to sift and to screen any chemical substance nominated using, where available, hazard data and environmental monitoring data to prioritise whether a substance may be a possible chemical of concern in England.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1547", "label" : {"_value" : "Biography information for Lord Benyon"} } , "answeringMemberPrinted" : {"_value" : "Lord Benyon"} , "dateOfAnswer" : {"_value" : "2022-10-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-10-27T12:18:07.313Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "13"} , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"} , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"} , "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Water: Ciprofloxacin"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government, further to the environmental concentration data collected in England and Wales 2015\u20132018 (Hayes & Murray et al., 2022) which suggests that the antibiotic ciprofloxacin poses a significant antimicrobial selection risk, whether they have considered its exclusion from the Water Framework Directive\u2019s Watch List and its place in the UK\u2019s monitoring procedures.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"} ], "uin" : "HL2578"} , {"_about" : "http://data.parliament.uk/resources/1522040", "AnsweringBody" : [{"_value" : "Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1522040/answer", "answerText" : {"_value" : "
The latest data indicates that the working age inactivity rate in the three months to August was 21.7%, up 0.6 percentage points on the previous three months and up 0.5 percentage points on the year. The headline employment rate for the three months to August was 75.5%, up 0.3 percentage points on the year. Demand for labour remains strong, with vacancies near record highs and significantly above pre-pandemic levels in the third quarter of 2022 (+51%). The latest data indicates that that the unemployment rate fell to 3.5% in the three months to August, the lowest rate since 1974.<\/em><\/p> <\/p> Our Plan for Patients, which the Department of Health and Social Care introduced in Parliament on 22 September, sets out our immediate priorities to support individuals to live healthier lives and to strengthen the resilience and health of the nation. This includes moving prevention services closer to the patient, expanding mental health support in schools and increasing support for people to start, stay and succeed in employment. Alongside this, the Department of Health and Social Care is currently reviewing all of its wider priorities with a focus on improving the health of the population across the breadth of the country.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4169", "label" : {"_value" : "Biography information for Viscount Younger of Leckie"}
}
, "answeringMemberPrinted" : {"_value" : "Viscount Younger of Leckie"}
, "dateOfAnswer" : {"_value" : "2022-10-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-10-27T12:55:38.283Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "14"}
, "answeringDeptShortName" : {"_value" : "Treasury"}
, "answeringDeptSortName" : {"_value" : "Treasury"}
, "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Public Health and Unemployment"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what assessment they have made of recent data from the Office for National Statistics regarding the UK employment rate for October 2022, which found that \"UK economic inactivity rate was estimated at 21.7%, which is 0.6 percentage points higher than the previous three-month period\"; and what steps they are taking to improve public health, given this is a potential contributory factor for such economic inactivity.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL2580"}
, {"_about" : "http://data.parliament.uk/resources/1522041", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1522041/answer", "answerText" : {"_value" : " Based only on the heavily edited short video clips obtained by trespassing at the Grafton Pet Crematorium premises, it is not possible for the Animal and Plant Health Agency to make a full and proper assessment of activities, or whether there were any breaches of regulations that protect human and animal health at premises which handle Animal By-Products. It will only be possible to make such assessments when Animal & Plant Health Agency is able to conduct an inspection and consider all the evidence at the premises.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1547", "label" : {"_value" : "Biography information for Lord Benyon"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Benyon"}
, "dateOfAnswer" : {"_value" : "2022-10-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-10-27T10:54:25.833Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "13"}
, "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Grafton Equine and Pet Cremation: Badgers"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what assessment they have made of the research undertaken by Keep the Ban regarding the handling of culled badgers at the Grafton Pet Crematorium; and what assessment they have made of the (1) human, and (2) animal, health risks as a consequence of the way handling was approached.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL2581"}
, {"_about" : "http://data.parliament.uk/resources/1522042", "AnsweringBody" : [{"_value" : "Department for Transport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1522042/answer", "answerText" : {"_value" : " The Government is committed to protecting the rights of passengers when travelling by air and consulted on a range of consumer issues in the Aviation Consumer Policy Reform Consultation. This included seeking views on additional administrative powers for the CAA to enforce consumer protection laws, and what more can be done to protect those with accessibility needs when travelling by air, including increased compensation for damage to wheelchairs and mobility equipment for domestic UK flights. We are currently conducting a comprehensive review and analysis of responses and will set out next steps shortly.<\/p> <\/p> The revocation of Article 16 of Regulation (EC) No 1107/2006, as retained in UK law following the UK\u2019s exit from the European Union (EU), does not mean that Regulation 1107/2006 is unenforceable. Article 16 was a provision addressed to EU Member States to lay down rules on penalties for breach of the Regulation, which the UK had already done. As the UK has left the EU, it is no longer required or appropriate.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4580", "label" : {"_value" : "Biography information for Baroness Vere of Norbiton"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Vere of Norbiton"}
, "dateOfAnswer" : {"_value" : "2022-10-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-10-18T13:39:25.217Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "27"}
, "answeringDeptShortName" : {"_value" : "Transport"}
, "answeringDeptSortName" : {"_value" : "Transport"}
, "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Aviation: Disability"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what plans they have to provide enforcement powers to the Civil Aviation Authority, commensurate with those available in the EU and the United States, given the withdrawal of Article 16 of EU regulation 1107/2006, which previously provided for action in individual breaches of the relevant code.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/395", "label" : {"_value" : "Biography information for Lord Blunkett"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Blunkett"}
], "uin" : "HL2582"}
, {"_about" : "http://data.parliament.uk/resources/1522043", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1522043/answer", "answerText" : {"_value" : " DWP are working with DHSC to make data available by the end of 2022.<\/p> <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4174", "label" : {"_value" : "Biography information for Baroness Stedman-Scott"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Stedman-Scott"}
, "dateOfAnswer" : {"_value" : "2022-10-25", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-10-25T14:19:46.94Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "29"}
, "answeringDeptShortName" : {"_value" : "Work and Pensions"}
, "answeringDeptSortName" : {"_value" : "Work and Pensions"}
, "date" : {"_value" : "2022-10-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Healthy Start Scheme"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government by what date the Department for Work and Pensions will resume the sharing of Healthy Start take-up data with the Department for Health and Social Care.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4704", "label" : {"_value" : "Biography information for Baroness Boycott"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Boycott"}
], "uin" : "HL2583"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&max-ddpModified.=2022-10-13T19%3A26%3A16.121Z&publisher.prefLabel=House+of+Lords&min-answer.questionFirstAnswered.=2020-03-12T16%3A04%3A59.13Z", "page" : 0, "startIndex" : 1, "totalResults" : 23806, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}